{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:41:40Z","timestamp":1792291300359,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110226","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:51:06Z","timestamp":1785858666000},"page":"110226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sapropterin (BH4) challenge in phenylketonuria: Responder or non-responder?"],"prefix":"10.1016","volume":"149","author":[{"given":"Nenad","family":"Blau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110226_bb0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110226_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","article-title":"Key European guidelines for the diagnosis and management of patients with phenylketonuria","volume":"5","author":"van Spronsen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ymgme.2026.110226_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110226_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109125","article-title":"European guidelines on diagnosis and treatment of phenylketonuria: first revision","volume":"145","author":"van Wegberg","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomized placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110226_bb0030","first-page":"483","article-title":"Sapropterin dihydrochloride for phenylketonuria and tetrahydrobiopterin deficiency, expert rev","volume":"5","author":"Blau","year":"2010","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0035","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ymgme.2011.08.017","article-title":"Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies","volume":"104","author":"Blau","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110226_bb0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","article-title":"High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002","volume":"77","author":"Bernegger","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0050","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa021654","article-title":"Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria","volume":"347","author":"Muntau","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110226_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2004.03.006","article-title":"The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"82","author":"Blau","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ymgme.2009.01.002","article-title":"Optimizing the use of sapropterin (BH4) in the management of phenylketonuria","volume":"96","author":"Blau","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2019.04.004","article-title":"International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria","volume":"127","author":"Muntau","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ejhg.2014.114","article-title":"Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria","volume":"23","author":"Wettstein","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110226_bb0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/humu.22980","article-title":"Genetics of phenylketonuria: then and now","volume":"37","author":"Blau","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2026.110226_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2018.06.011","article-title":"Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria","volume":"125","author":"Himmelreich","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41436-018-0081-x","article-title":"Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria","volume":"21","author":"Garbade","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110226_bb0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110226_bb0095","article-title":"Significance of utilizing in silico structural analysis and phenotypic data to characterize phenylalanine hydroxylase variants: a PAH landscape","volume":"143","author":"Himmelreich","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70220","article-title":"Integrating functional consequence annotation with PAH allelic phenotype values refines prediction of tetrahydrobiopterin responsiveness","volume":"49","author":"Himmelreich","year":"2026","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/ped.14399","article-title":"Guide for diagnosis and treatment of hyperphenylalaninemia","volume":"63","author":"Shintaku","year":"2021","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2026.110226_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70154","article-title":"Age-dependent variation in blood biopterin peaks following oral tetrahydrobiopterin administration in phenylketonuria","volume":"49","author":"Kitayama","year":"2026","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2019.12.011","article-title":"Does the 48-hour BH4 loading test miss responsive PKU patients?","volume":"129","author":"van Wegberg","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/humu.9117","article-title":"Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency","volume":"21","author":"Lindner","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2026.110226_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2004.06.007","article-title":"Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype","volume":"83","author":"Desviat","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0130","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ymgme.2005.07.024","article-title":"Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin","volume":"86","author":"Belanger-Quintana","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10545-006-0096-3","article-title":"The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency","volume":"29","author":"Leuzzi","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10545-006-0425-6","article-title":"Pharmacokinetics of orally administered tetrahydrobiopterin in patients with phenylalanine hydroxylase deficiency","volume":"29","author":"Zurfluh","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride: a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ymgme.2007.07.013","article-title":"Effects of tetrahydrobiopterin and phenylalanine on in vivo human phenylalanine hydroxylase by phenylalanine breath test","volume":"92","author":"Okano","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.20637","article-title":"Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"29","author":"Zurfluh","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2026.110226_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2009.03.009","article-title":"Genotype-predicted tetrahydrobiopterin responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase deficiency","volume":"97","author":"Karacic","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/jhg.2009.37","article-title":"A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin","volume":"54","author":"Dobrowolski","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110226_bb0170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110226_bb0175","first-page":"37","article-title":"Recommendations about the use of tetrahydrobiopterin in phenylketonuria","volume":"21","author":"Swiss Group for Inborn Errors of Metabolism","year":"2010","journal-title":"Paediatrica"},{"key":"10.1016\/j.ymgme.2026.110226_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10545-009-9002-0","article-title":"Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation","volume":"33","author":"Nielsen","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2010.11.158","article-title":"Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population","volume":"102","author":"Dobrowolski","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2223\/JPED.2090","article-title":"Tetrahydrobiopterin responsiveness of patients with phenylalanine hydroxylase deficiency","volume":"87","author":"Giugliani","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110226_bb0195","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.ymgme.2011.09.019","article-title":"Optimized loading test to evaluate responsiveness to tetrahydrobiopterin (BH4) in Brazilian patients with phenylalanine hydroxylase deficiency","volume":"104","author":"Nalin","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/jhg.2011.10","article-title":"Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan","volume":"56","author":"Okano","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110226_bb0205","first-page":"109","article-title":"A systematic review of BH4 (sapropterin) for the adjuvant treatment of phenylketonuria","volume":"8","author":"Lindegren","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110226_bb0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12325-013-0011-x","article-title":"Testing for tetrahydrobiopterin responsiveness in patients with hyperphenylalaninemia due to phenylalanine hydroxylase deficiency","volume":"30","author":"Cerone","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ymgme.2026.110226_bb0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/humu.22320","article-title":"Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria","volume":"34","author":"Heintz","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2026.110226_bb0220","first-page":"101","article-title":"Influence of PAH genotype on sapropterin response in PKU: results of a single-center cohort study","volume":"13","author":"Leuders","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110226_bb0225","first-page":"55","article-title":"The molecular bases of phenylketonuria in New South Wales, Australia: mutation profile and correlation with tetrahydrobiopterin responsiveness","volume":"11","author":"Ho","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110226_bb0230","first-page":"77","article-title":"Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran","volume":"2","author":"Setoodeh","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110226_bb0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13023-015-0375-x","article-title":"Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness","volume":"10","author":"Jeannesson-Thivisol","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0240","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/pr.2015.167","article-title":"Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria","volume":"78","author":"Tao","year":"2015","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.110226_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13023-016-0394-2","article-title":"The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?","volume":"11","author":"Anjema","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110226_bb0250","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1038\/s41598-017-06462-y","article-title":"The predictive value of genetic analyses in the diagnosis of tetrahydrobiopterin (BH4)-responsiveness in Chinese phenylalanine hydroxylase deficiency patients","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.110226_bb0255","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10528-018-9858-5","article-title":"Functional characterization of novel phenylalanine hydroxylase p.Gln226Lys mutation revealed its non-responsiveness to tetrahydrobiopterin treatment in hepatoma cellular model","volume":"56","author":"Klaassen","year":"2018","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.ymgme.2026.110226_bb0260","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1515\/jpem-2018-0503","article-title":"Response to sapropterin hydrochloride (Kuvan) in children with phenylketonuria (PKU): a clinical trial","volume":"32","author":"Eshraghi","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104536","article-title":"Tetrahydrobiopterin responsiveness in phenylalanine hydroxylase deficient patients from North-east of Iran: genotype-phenotype correlation, identification of a novel mutation and 7 new responsive genotypes","volume":"65","author":"Khaghani","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2026.110226_bb0270","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(24)01556-3","article-title":"Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial","volume":"404","author":"Muntau","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110226_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2026.110110","article-title":"Sepiapterin: from sapropterin to next-generation therapy","volume":"148","author":"Blau","year":"2026","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110226_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70067","article-title":"Personalized genotype-based approach for treatment of phenylketonuria","volume":"48","author":"Gundorova","year":"2025","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:38:03Z","timestamp":1790368683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226005093"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110226","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sapropterin (BH4) challenge in phenylketonuria: Responder or non-responder?","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110226"}}